International Availability and Price of Ultraexpensive Drugs in Medicare Part D
JAMA Network Open · 01.05.2026 · 9 (5) · e2610053
DOI: 10.1001/jamanetworkopen.2026.10053 ↗Kurz gefasst
Fachartikel in der Zeitschrift JAMA Network Open, online erschienen am 01.05.2026. Verfasst von Allison S Kim und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Health Management and Policy, Georgetown University School of Health, Washington, DC. Die Arbeit nennt 6 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
This cohort study characterizes ultraexpensive drugs in Medicare Part D and examines their availability and relative prices across industrialized countries.
Autor:innen und Institutionen
- Department of Health Management and Policy, Georgetown University School of Health, Washington, DC.
- Cancer Prevention and Control Program, Georgetown-Lombardi Comprehensive Cancer Center, Washington, DC.
Zitieren
APA
Kim, A. S., & Kang, S. Y. (2026). International Availability and Price of Ultraexpensive Drugs in Medicare Part D. JAMA Network Open, 9(5), e2610053. https://doi.org/10.1001/jamanetworkopen.2026.10053
Vancouver
Kim AS, Kang SY. International Availability and Price of Ultraexpensive Drugs in Medicare Part D. JAMA Network Open. 2026;9(5):e2610053. doi:10.1001/jamanetworkopen.2026.10053
BibTeX
@article{Kim2026,
author = {Kim, Allison S and Kang, So-Yeon},
title = {International Availability and Price of Ultraexpensive Drugs in Medicare Part D},
journal = {JAMA Network Open},
year = {2026},
volume = {9},
number = {5},
pages = {e2610053},
doi = {10.1001/jamanetworkopen.2026.10053}
}
EUVIMED